TY - JOUR
T1 - Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women
AU - Dillon, Edgar L.
AU - Sheffield-Moore, Melinda
AU - Paddon-Jones, Douglas
AU - Gilkison, Charles
AU - Sanford, Arthur P.
AU - Casperson, Shanon L.
AU - Jiang, Jie
AU - Chinkes, David L.
AU - Urban, Randall J.
N1 - Funding Information:
This work was supported by National Institutes of Health (NIH)/National Institute on Aging Claude D. Pepper Older Americans Independence Center Grant P30 AG024832 (to R.J.U.), NIH/National Institute on Aging R01 AG21539 (to M.S.-M.), NIH/National Center for Research Resources, United States Public Health Service, and General Clinical Research Center Grant M01 RR00073.
PY - 2009/5
Y1 - 2009/5
N2 - Context: Inadequate dietary protein intake has been implicated in sarcopenia. Objective and Design: The objectives of this study were to determine whether: 1) chronic essential amino acid (EAA) supplementation improves postabsorptive muscle protein fractional synthesis rate (FSR), lean body mass (LBM), and one-repetition maximum muscle strength, and androgen receptor and IGF-I muscle protein expression; and 2) the acute anabolic response to EAA ingestion is preserved after a 3-month supplementation period. Using a randomized, double-blinded, placebo-controlled design, older women (68 ± 2 yr) were assigned to receive either placebo (n = 7), or 15 g EAA/d [supplemented treatment group (SUP)] (n = 7) for 3 months. Metabolic outcomes were assessed in association with stable isotope studies conducted at 0 and 3 months. Setting: The study was performed at The University of Texas Medical Branch General Clinical Research Center. Results: Ingestion of 7.5 g EAA acutely stimulated FSR in both groups at 0 months (P < 0.05). Basal FSR at 3 months was increased in SUP only. The magnitude of the acute response to EAA was unaltered after 3 months in SUP. LBM increased in SUP only (P < 0.05). One-repetition maximum strength remained unchanged in both groups. Basal IGF-I protein expression increased in SUP after 3 months (P = 0.05), with no changes in androgen receptor or total and phosphorylated Akt, mammalian target of rapamycin, S6 kinase, and 4E-binding protein. Conclusions: EAA improved LBM and basal muscle protein synthesis in older individuals. The acute anabolic response to EAA supplementation is maintained over time and can improve LBM, possibly offsetting the debilitating effects of sarcopenia.
AB - Context: Inadequate dietary protein intake has been implicated in sarcopenia. Objective and Design: The objectives of this study were to determine whether: 1) chronic essential amino acid (EAA) supplementation improves postabsorptive muscle protein fractional synthesis rate (FSR), lean body mass (LBM), and one-repetition maximum muscle strength, and androgen receptor and IGF-I muscle protein expression; and 2) the acute anabolic response to EAA ingestion is preserved after a 3-month supplementation period. Using a randomized, double-blinded, placebo-controlled design, older women (68 ± 2 yr) were assigned to receive either placebo (n = 7), or 15 g EAA/d [supplemented treatment group (SUP)] (n = 7) for 3 months. Metabolic outcomes were assessed in association with stable isotope studies conducted at 0 and 3 months. Setting: The study was performed at The University of Texas Medical Branch General Clinical Research Center. Results: Ingestion of 7.5 g EAA acutely stimulated FSR in both groups at 0 months (P < 0.05). Basal FSR at 3 months was increased in SUP only. The magnitude of the acute response to EAA was unaltered after 3 months in SUP. LBM increased in SUP only (P < 0.05). One-repetition maximum strength remained unchanged in both groups. Basal IGF-I protein expression increased in SUP after 3 months (P = 0.05), with no changes in androgen receptor or total and phosphorylated Akt, mammalian target of rapamycin, S6 kinase, and 4E-binding protein. Conclusions: EAA improved LBM and basal muscle protein synthesis in older individuals. The acute anabolic response to EAA supplementation is maintained over time and can improve LBM, possibly offsetting the debilitating effects of sarcopenia.
UR - http://www.scopus.com/inward/record.url?scp=66149141889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66149141889&partnerID=8YFLogxK
U2 - 10.1210/jc.2008-1564
DO - 10.1210/jc.2008-1564
M3 - Article
C2 - 19208731
AN - SCOPUS:66149141889
SN - 0021-972X
VL - 94
SP - 1630
EP - 1637
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 5
ER -